The Omya facility in Kemalpa?a/Izmir has received Turkish Health Authority accreditation to manufacture calcium carbonate as an active pharmaceutical ingredient (API) in line with the strictest quality requirements and industry-leading GMP-compliant manufacturing practices set out in ICH Q7.